Annual Meeting

Out with the old, in with the nucleus

Learn about the Discover BMB 2024 symposium on signaling mechanisms in the nucleus
Glen Liszczak Aaron Johnson
By Glen Liszczak and Aaron Johnson
Sept. 21, 2023

Are you tired of binging reruns on Netflix?  Maybe you need a break from reality TV but you’re not sure where to turn for high-quality entertainment?  Look no further — the nucleus has it all.  There’s mystery, murder, machines of extraordinary complexity and visually stunning landscapes. 

Stories in nuclear signaling are unraveling at an unprecedented pace thanks to technological and conceptual advances in chemistry, biochemistry and cell biology. Our speakers will address long-standing questions about organism development, cellular identity and the genetic basis for disease. 

Submit an abstract

Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.

You will hear about how cutting-edge interdisciplinary approaches are being used to uncover new regulatory mechanisms underlying transcription, genome structure, and other phenomena in the nucleus. We will also discuss how rapid progress in the field is inspiring new therapeutic approaches for diseases related to dysfunctional nuclear processes.

You don’t want to miss this — even the cytosol junkies will be on the edge of their seats.

Keywords:  Enzyme mechanism, genetics and disease, chemical probes, transcription regulation, chromatin modifications, genome structure.

Who should attend: You. Our speakers span a wide breadth of biological phenomena, scientific disciplines and technologies. We have something for everyone. Current projections: standing room only.

Your session’s theme song“Journey to the Island” by John Williams

This song is about the most important genetics experiment ever performed.

This session is powered by “hot, nasty, bad-*ss speed.” — Eleanor Roosevelt, Talladega Nights

Signaling mechanisms in the nucleus

Chemical strategies to study nuclear processes

Chair: Aaron Johnson

Anna MappUniversity of Michigan

Glen LiszczakUniversity of Texas Southwestern Medical Center

Oliver BellUniversity of Southern California Kerk School of Medicine

Minkui LuoMemorial Sloan Kettering Cancer Center

Chromatin organization, replication and repair

Chair: Katharine Diehl

Aaron StreetsUniversity of California, Berkeley

Aaron JohnsonUniversity of Colorado Anschutz Medical Campus

Carl WuJohns Hopkins University

Serena Sanulli, Stanford University

Chromatin modifications in the nucleus

Chair: Glen Liszczak

Alex RuthenbergUniversity of Chicago

Katharine DiehlUniversity of Utah

Tim StasevichColorado State University

Phil ColeHarvard University

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Glen Liszczak
Glen Liszczak

Glen Liszczak is an assistant professor in the biochemistry department at the University of Texas Southwestern Medical Center.

Aaron Johnson
Aaron Johnson

Aaron Johnson is an associate professor in the biochemistry and molecular genetics department at the University of Colorado School of Medicine.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

A biological camera: How AI is transforming retinal imaging
Feature

A biological camera: How AI is transforming retinal imaging

Oct. 15, 2025

AI is helping clinicians see a more detailed view into the eye, allowing them to detect diabetic retinopathy earlier and expand access through tele-ophthalmology. These advances could help millions see a clearer future.

AI in the lab: The power of smarter questions
Essay

AI in the lab: The power of smarter questions

Oct. 14, 2025

An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Feature

Training AI to uncover novel antimicrobials

Oct. 9, 2025

Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Journal News

AI-designed biomarker improves malaria diagnostics

Oct. 8, 2025

Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Journal News

Matrix metalloproteinase inhibitor reduces cancer invasion

Oct. 8, 2025

Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.

Antibiotic sensor directly binds drug in resistant bacteria
Journal News

Antibiotic sensor directly binds drug in resistant bacteria

Oct. 8, 2025

Researchers at Drexel University uncover how the vancomycin-resistant bacterial sensor binds to the antibiotic, offering insights to guide inhibitor design that restores antibiotic effectiveness against hospital-acquired infections.